entertainment -WSS

entertainment

author：hotspot 2025-09-06 02:04:22 - browse：484

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Advances in CAR

Wikipedia

focus

WSS

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Medicaid rebukes states for mistakenly disenrolling children

Why we need mandatory labeling of GMO products

Crinetics acromegaly drug succeeds in late

Weighted lottery helped low

The Bio Revolution is changing business and society

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

New air purifier tech could be key to improving indoor air quality

Guardant Health colon cancer test endorsed by FDA advisory panel

Supreme Court strikes down use of affirmative action

New research sheds light on how often breast cancer is overdiagnosed

Medicare details structure of new drug price negotiation program

Why we need mandatory labeling of GMO products

Wildfire smoke exposes gaps in outdoor worker protections

Listen: Biogen's potential pivot, & Illumina's next chapter

Hepatitis C has a cure — but many Americans still lack access to it

Hospitals need to get ahead of regulations on climate change

focus

What American doctors can learn from their Israeli counterparts

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

How to protect patients from sexual assault

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

AstraZeneca chief proposes a novel edit to the drug pricing bill

Trump surgeon general acknowledges mistakes during Covid

Wikipedia

Wikipedia

focus

explore